| NK cell-based immunotherapies in cancer MH Shin, J Kim, SA Lim, J Kim, SJ Kim, KM Lee Immune network 20 (2), 2020 | 119 | 2020 |
| Current insights into combination therapies with MAPK inhibitors and immune checkpoint blockade MH Shin, J Kim, SA Lim, J Kim, KM Lee International journal of molecular sciences 21 (7), 2531, 2020 | 73 | 2020 |
| Clinical progress of nanomedicine-based RNA therapies SA Lim, A Cox, M Tung, EJ Chung Bioactive Materials 12, 203-213, 2022 | 31 | 2022 |
| Strategies to deliver RNA by nanoparticles for therapeutic potential A Cox, SA Lim, EJ Chung Molecular aspects of medicine 83, 100991, 2022 | 7 | 2022 |
| Combination of TEW-7197 and adoptively transferred NK cells leads to Improved Antitumor Responses in vivo J Kim, SA Lim, TJ Kim, S Lim, J Kim, J Kim, J Kim, E Lee, S Park, SJ Kim, ... The Journal of Immunology 204 (1_Supplement), 241.45-241.45, 2020 | 1 | 2020 |
| Natural Killer Cell‐Derived Extracellular Vesicles as Potential Anti‐Viral Nanomaterials SA Lim, N Ho, S Chen, EJ Chung Advanced Healthcare Materials, 2304186, 2024 | | 2024 |
| Antibody-Immobilized< wbr> Nanofiber Scaffolds for the Delivery of Human Tumor Antigen-Specific Cytotoxic T Lymphocytes E Lee, JNP Jia, TJ Kim, S Lim, J Kim, J Kim, J Kim, J Kim, S Park, K Lee The Journal of Immunology 204 (1_Supplement), 159.55-159.55, 2020 | | 2020 |
